Literature DB >> 17173512

Ataxia: an early indicator in high altitude cerebral edema.

Tianyi Wu1, Shouquan Ding, Jinliang Liu, Jianhou Jia, Ruichen Dai, Baozhu Liang, Jizhui Zhao, Detang Qi.   

Abstract

Wu, Tianyi, Shouquan Ding, Jinliang Liu, Jianhou Jia, Ruichen Dai, Baozhu Liang, Jizhui Zhao, and Detang Qi. Ataxia: an early indicator in high altitude cerebral edema. High Alt. Med. Biol. 7:275-280, 2006.--As a result of industrial development in the western region of China, in 2001 the Chinese government decided to build Qinghai-Tibetan Railway. The new railroad stretches 1118 km from Golmud (2808 m) to Lhasa (3658 m), with more than three-quarter of the distance above 4000 m, through the Mt. Kun Lun and Tanggula ranges. From the beginning of the project on June, 29, 2001, to the end of the year of 2003, about 74,735 construction workers worked in the harsh climate, in adverse circumstances and a low-barometric-pressure environment. The construction provided an opportunity for the investigation and study of acute mountain sickness (AMS), high altitude pulmonary edema (HAPE), and high altitude cerebral edema (HACE). These altitude illnesses were very common in the construction workers. From July 1, 2001, to October 31, 2003, the overall incidence of AMS, HAPE, and HACE in the total workers was approximately 45%-95%, 0.49%, and 0.26%, respectively. Altitude illnesses were studied at two hospitals near the construction site. One hospital is located on the Fenghuoshan (Mt. Wind-gap) at an altitude of 4779 m (PB 428 torr), and the second hospital is situated in the Kekexili area at an altitude of 4505 m (PB 440 torr). Kekexili is a sparsely populated zone because the weather conditions are very bad all year round. These two hospitals received patients from the construction sites, where workers were working at altitudes between 4464 and 4905 m. A total of 8014 workers were treated at Fenghuoshan and 5488 were in Kekexili over the past 3 years. According to local guidance about proper medical care, workers ascending to high altitude should be examined physically, complete an AMS questionnaire, and be monitored for ataxia as an early warning sign of the impending, more serious aspects of HACE. The onset of HACE is frequently characterized by an ataxic gait, as reported since the middle of the 20th century (Gray et al., 1971; Wilson, 1973; Houston and Dickinson, 1975; Dickinson, 1979; Clarke, 1988; Hackett and Oelz, 1992; Hackett, 2002; Hackett and Roach, 2004). However, there are no detailed analyses of ataxia in HACE. This paper considers the relation between ataxia and HACE and its frequency, significance, and importance.

Entities:  

Mesh:

Year:  2006        PMID: 17173512     DOI: 10.1089/ham.2006.7.275

Source DB:  PubMed          Journal:  High Alt Med Biol        ISSN: 1527-0297            Impact factor:   1.981


  12 in total

1.  Overactivation of corticotropin-releasing factor receptor type 1 and aquaporin-4 by hypoxia induces cerebral edema.

Authors:  Shao-Jun Chen; Jia-Fang Yang; Fan-Ping Kong; Ji-Long Ren; Ke Hao; Min Li; Yuan Yuan; Xin-Can Chen; Ri-Sheng Yu; Jun-Fa Li; Gareth Leng; Xue-Qun Chen; Ji-Zeng Du
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-21       Impact factor: 11.205

2.  High-altitude cerebral edema or acute demyelinating encephalomyelitis in the Himalayas.

Authors:  Ole Hensel; Piyush Niroula; Raju Paudel; Tshewang Sherpa; Torsten Kraya; Peter Presek; Stephan Zierz
Journal:  Neurol Clin Pract       Date:  2018-02

Review 3.  Physiology and pathophysiology at high altitude: considerations for the anesthesiologist.

Authors:  Kay B Leissner; Feroze U Mahmood
Journal:  J Anesth       Date:  2009-11-18       Impact factor: 2.078

4.  Population level determinants of acute mountain sickness among young men: a retrospective study.

Authors:  Xiaoxiao Li; Fasheng Tao; Tao Pei; Haiyan You; Yan Liu; Yuqi Gao
Journal:  BMC Public Health       Date:  2011-09-28       Impact factor: 3.295

5.  Sleep quality changes in insomniacs and non-insomniacs after acute altitude exposure and its relationship with acute mountain sickness.

Authors:  Xu-Gang Tang; Ji-Hang Zhang; Xu-Bin Gao; Qian-Ning Li; Jia-Bei Li; Jie Yu; Jun Qin; Lan Huang
Journal:  Neuropsychiatr Dis Treat       Date:  2014-07-31       Impact factor: 2.570

6.  Isolated psychosis during exposure to very high and extreme altitude - characterisation of a new medical entity.

Authors:  Katharina Hüfner; Hermann Brugger; Eva Kuster; Franziska Dünsser; Agnieszka E Stawinoga; Rachel Turner; Iztok Tomazin; Barbara Sperner-Unterweger
Journal:  Psychol Med       Date:  2017-12-05       Impact factor: 7.723

7.  The effects of respiratory inhaled drugs on the prevention of acute mountain sickness.

Authors:  Xiaomei Wang; Hong Chen; Rong Li; Weiling Fu; Chunyan Yao
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.889

8.  Atypical High-Altitude Cerebral Edema Presentation at an Altitude of Less Than 3000 Meters Elevation: A Case Report.

Authors:  Todd Bolotin; Kayla E Prokopakis; Bruce Becker
Journal:  Open Access Emerg Med       Date:  2022-03-29

9.  NRF1-mediated microglial activation triggers high-altitude cerebral edema.

Authors:  Xueting Wang; Guijuan Chen; Baolan Wan; Zhangji Dong; Yan Xue; Qianqian Luo; Dan Wang; Yapeng Lu; Li Zhu
Journal:  J Mol Cell Biol       Date:  2022-09-19       Impact factor: 8.185

10.  Mortality on Mount Everest, 1921-2006: descriptive study.

Authors:  Paul G Firth; Hui Zheng; Jeremy S Windsor; Andrew I Sutherland; Christopher H Imray; G W K Moore; John L Semple; Robert C Roach; Richard A Salisbury
Journal:  BMJ       Date:  2008-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.